Table 2. An outline of the chemotherapy types and how many patients received each.

Type of Chemotherapy	Number of Patients who received these treatments as 1st line	Number of Patients who received these treatments 2nd line or later
Adriamycin/Ifosfamide	10	2
Taxane based*	3	4
Tyrosine Kinase Inhibitors (TKIs)**	1	2
Experimental †	1	1
Other ‡	5	5
Patients who received multiple regimens	9

*Taxane based regimens used: Carboplatinum/Taxotere, gemcitabine/docetaxol or taxotere, docetaxol, paclitaxel

**TKIs used: Imatinib, Sunitinib

^†Experimental treatments used: GARFT inhibitor, anti-CD40 monoclonal antibody

^‡Other treatments used: Dacarbazine, pemetrexed, Rapamycin, doxorubicin/cisplatinum, adriamycin/carboplatinum, cytarabine, avastin, cisplatinum, doxorubicin/ifosfamide

Note: Four of the five patients with benign histology who received chemotherapy had large tumors and two had incomplete resections